The Genetics of Type I and Type II Diabetes: Analysis by Recombinant DNA Methodology

  • M. Alan Permutt
  • Teresa Andreone
  • John Chirgwin
  • Steve Elbein
  • Peter Rotwein
  • Matthew Orland
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 189)


Susceptibility to IDDM is linked to the HLA-D locus on the short arm of chromosome 6, a region believed to be involved in the process of communication between cells which determines immune responses. Presumably an HLA molecule encoded by this region, unable to present a particular antigenic pathogen to the immune system, is inherited. The HLA-DR locus is quite complex, however. The gene which codes for this defective molecule may be identified by a combination of use of monoclonal antibodies and cloned gene probes which specifically hybridize to various portions of this region. Investigators are searching for HLA-DR4 containing chromosomes in IDDM which show similar patterns of restriction enzyme polymorphism. Hopefully, complete structural analysis of these related sequences will provide information about the mechanisms which confer susceptibility to develop IDDM.

A strong genetic component is involved in NIDDM evidenced by a high concordance in monozygotic twins. Nevertheless, there is much evidence of genetic heterogeneity. At the present time no clear cut genetic marker has been defined. The human insulin gene has been cloned and by Southern blot hybridization analysis of peripheral leukocyte DNA, the insulin gene locus is being evaluated as a possible contributor to the genetic defect. Population studies at the present time have not identified any particular polymorphic insulin allele associated with NIDDM. Population studies are complicated by heterogeneity of NIDDM, racial and ethnic differences, and heterogeneity of insulin alleles. Linkage analysis in family studies will provide an alternative approach to population studies to determine what role if any the insulin gene plays in the genetic component of this disease. Because NIDDH is heterogeneous and perhaps polygenic in nature, these linkage analyses in families with NIDDM can be extended to other genes when they are cloned such as that coding for the insulin receptor.

The familial aggregation of diabetes has long been noted (see ref. 1 for review). In relatives of diabetics, the prevalence ranges from 10–30%, while it is variously estimated to be between 0.1–3% in the general population. But familial aggregation of a trait may be caused either by genetic or environmental factors. One approach to dissecting the contribution of these factors is the study of concordance in twins. Pyke and associates2 observed that overall identical twins always show a higher concordance rate than dizygotic twins, irrespective of their age of diagnosis. Furthermore, they noted that identical twins of younger onset are often discordant for diabetes while identical twins of older onset are usually concordant. In a study of 200 pairs of monozygotic twins,3 the concordance of Type I or insulin dependent diabetes (IDDM) was 80 of 147 twin pairs (54%). In contrast, 48 of 53 Type II or non-insulin dependent diabetes (NIDDH) pairs (91%) were concordant for diabetes. Thus, while genetic factors are important in both types of diabetics, a strong environmental component makes genetic analysis of IDDH more complex.


Identical Twin Familial Aggregation Insulin Gene Odds Ration American Black 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J.I. Rotter, and D.L. Rimoin, Genetics, in: “Handbook of Diabetes Mellitus,” M. Brownlee, ed., Gorland STPM Press, New York (1980).Google Scholar
  2. 2.
    R.B. Tattersall, D.A. Pyke, Diabetes in identical twins, Lancet ii: 1120–1125 (1972).Google Scholar
  3. 3.
    A.H. Barnett, C. Eff, R.D.G. Leslie, and D.A. Pyke, Diabetes in identical twins, Diabetologia 20: 87–93 (1981).PubMedCrossRefGoogle Scholar
  4. 4.
    J. Neurp, P. Platz, O. Ortved-Anderson, M. Christy, J. Egeberg, J. Lyngsoe, J.E. Poulsen, L.P. Ryder, M. Thomsen, and A. Svejgaard, in: “The Genetics of Diabetes Mellitus,” W. Creutzfeldt, J. Kobberling, and J. V. Neel, eds., SpringerVerlag (1976).Google Scholar
  5. 5.
    H. Thomsen, P. Platz, 0.0. Andersen, M. Christy, J. Lyngsoe, J. Nerup, K. Rasmussen, L.P. Ryder, L.S. Nielsen, and A. Sveigaard, MLC typing in juvenile diabetes mellitus and idiopathic Addison’s disease, Transplant Res. 22: 125–147 (1975).Google Scholar
  6. 6.
    N.R. Farid, and J.C. Bear, The human major histocompatibility complex and endocrine disease, Endocrine Rev. 2: 50–86 (1981).CrossRefGoogle Scholar
  7. 7.
    M. Christy, G. Green, and B. Christan, Studies of the HLA system and IDDM, Diabetes Care 2: 209–214 (1979).PubMedCrossRefGoogle Scholar
  8. 8.
    J. Neurp, M. Christy, A. Green, M. Hauge, P. Platz, L.P. Ryder, A. Svejgaard, and H.L. Thomsen, HLA and insulin dependent diabetes - population studies, in: “The Genetics of Diabetes Mellitus. Serono Symposium. Vol 47,” J. Kobberling and R. Tattersall, eds., Academic Press (1982).Google Scholar
  9. 9.
    A.N. Gorsuch, K.H. Spencer, E. Wolf, and A.G. Cudworth, HLA and family studies, in: “The Genetics of Diabetes Mellitus. Serono Symposium. Vol. 47,” J. Kobberling and R. Tattersall, eds., Academic Press (1982).Google Scholar
  10. 10.
    S. Shaw and A. McMichael, HLA class II antigens and monclonal antibodies, Nature 306: 538–539 (1983).PubMedCrossRefGoogle Scholar
  11. 11.
    Y.W. Kan, and A.H. Dozy, Polymorphism of DNA sequence adjacent to human B-globin structural gene: relationship to sickle mutation, Proc. Natl. Acad. Sci. USA 75: 5631–5635 (1978).PubMedCrossRefGoogle Scholar
  12. 12.
    A.J. Jeffreys, DNA sequence variants in theGY-,AY-, and Sand 8-globin genes in man, Cell 18: 1–10 (1979).PubMedCrossRefGoogle Scholar
  13. 13.
    J.F. Gusella, N.S. Wexler, P.H. Conneally, S.L. Naylor, M.A. Anderson, R.E. Tanzi, P.C. Watkins, K. Ottina, H.R. Wallace, A.Y. Sakaguchi, A.B. Young, I. Shoulson, E. Bonilla, and J.S. Martin, A polymorphic DNA marker genetically linked to Huntington’s disease, Nature 306: 234–238 (1983).PubMedCrossRefGoogle Scholar
  14. 14.
    D. Owerbach, A. Lernmark, P. Platz, L.P. Ryder, L. Rask, P.A. Peterson, and J. Ludvigsson, HLA-D region 13-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals, Nature 303: 815–817 (1983).PubMedCrossRefGoogle Scholar
  15. 15.
    D. Owerbach, B. Hagglof, A. Lernmark, and G. Holmgren, Susceptibility in insulin-dependent diabetes defined by restriction enzyme polymorphism of HLA-D region genomic DNA, Submitted to Diabetes. Google Scholar
  16. 16.
    C.R. Cantor, Huntington’s disease, Charting the path to the gene, Nature 308: 404–405 (1984).PubMedCrossRefGoogle Scholar
  17. 17.
    J.D. Baird, Is obesity a factor in the aetiology of noninsulindependent diabetes?, in: “The Genetics of Diabetes Mellitus. Serono Symposim. Vol. 47,” J. Kobberling, and R. Tattersall, eds., Academic Press (1982).Google Scholar
  18. 18.
    J. Kobberling, Genetic heterogeneities with idiopathic diabetes, in: “The Genetics of Diabetes Mellitus,” W. Creutzfeldt, J. Kobberling, and J.V. Neel, eds. Springer-Verlag, Berlin (1976).Google Scholar
  19. 19.
    P.Z. Zimmet, R.L. Kirk, and S.W. Serjeantson, Genetic and environmental interactions for non-insulin-dependent diabetes in high prevalence Pacific populations, in: “The Genetics of Diabetes Mellitus. Serono Symposium. Vol 47,” J. Kobberling, and R. Tattersall, eds., Academic Press, (1982).Google Scholar
  20. 20.
    W.C. Knowler, P.J. Savage, M. Nagulesparan, B.V. Howar, D.J. Pettitt, J.R. Lisse, S.L. Aronoff, and P.H. Bennett, Obesity, insulin resistance and diabetes mellitus in the Pima Indians, in: “The Genetics of Diabetes Mellitus. Serono Symposium. Vol. 47,” J. Kobberling and R. Tattersall, eds., Academic Press (1982).Google Scholar
  21. 21.
    R.B. Tattersall, and S.S. Fajans, A difference between the inheritance of classical juvenile onset and maturity onset types diabetes in young people, Diabetes 24: 44–53 (1975).PubMedCrossRefGoogle Scholar
  22. 22.
    S.S. Fajans, M.C. Coultier, and R.L. Crowther, Clincial and etiologic heterogeneity of idiopathic diabetes mellitus, Diabetes 27: 1112–1125 (1978).PubMedGoogle Scholar
  23. 23.
    D.A. Pyke, Diabetes: The genetic connections, Diabetologia 17: 333–343 (1979).PubMedCrossRefGoogle Scholar
  24. 24.
    R.D.G. Leslie, and D.A. Pyke, D.A.: Chloropropamide-alcohol flushing: A dominantly inherited trait associated with diabetes, Br. Med. J. 2: 1519–1520 (1978).PubMedCrossRefGoogle Scholar
  25. 25.
    D.A. Pyke, and R.D.G. Leslie, Chloropropamide-alcohol flushing: A definition of its relation to non-insulin dependent diabetes, Br. Med. J. 2: 1521–1522 (1978).PubMedCrossRefGoogle Scholar
  26. 26.
    S.N.T. Fui, H. Keen, J. Jarrett, V. Gossain, and P. Marsden, Test for Chlorpropamide-alcohol flush becomes positive after prolonged chlorpropamide treatment in insulin-depedent and noninsulin dependent diabetics, New Engl. J. Med. 309: 93–96 (1983).Google Scholar
  27. 27.
    N. Maclean, and R.F. Ogilivie, Quantitative estimation of the pancreatic tissue in diabetic subjects, Diabetes 4: 367–376 (1955).PubMedGoogle Scholar
  28. 28.
    R.L. White, D. Barker, T. Holm, J. Berkowitz, M. Lepert, W. Cavenee, R. Leach, and D. Drayna, Approaches to linkage analysis in the human, in: “Banbury Report 14. Recombination DNA Applications to Human Disease,” C.T. Caskey, and R.L. White, eds., Cold Spring Harbor Laboratory (1983).Google Scholar
  29. 29.
    S.C.H. Kwok, S.J. Chan, A.H. Rubenstein, R. Poucher, and D.F. Steiner, Loss restriction endonuclease cleavage site in the gene of a structurally abnormal human insulin, Biochem. Biophys. Res. Comm., 98: 844–849 (1981).CrossRefGoogle Scholar
  30. 30.
    S.C.M. Kwok, D.F. Steiner, A.H. Rubenstein, and H.S. Tager, Identification of a point mutation in the human insulin gene giving rise to a structurally abnormal insulin (Insulin Chicago), Diabetes 32: 872–875 (1983).PubMedCrossRefGoogle Scholar
  31. 31.
    S.E. Antonarakis, S.H. Orkin, T. Cheng, A.F. Scott, J.P. Sexton, S.P. Trusko, S. Charache, and A.H. Kazazian, Jr., B-Thalessemia in American Blacks: Novel mutations in the “TATA” box and an acceptor splice site, PNAS 81: 1154–1158 (1984).PubMedCrossRefGoogle Scholar
  32. 32.
    G.I. Bell, R. Pictet, and W.J. Rutter, Analysis of the regions flanking the human insulin gene and sequence of an Alu family member, Nucleic Acids Res. 8: 4001–4008 (1980).CrossRefGoogle Scholar
  33. 33.
    P. Rotwein, R. Chyn, J. Chirgwin, B. Cordell, H. Goodman, and M.A. Permutt, Polymorphism in the 5’-flanking region of the human insulin gene and its possible relation to Type 2 diabetes, Science 213: 1117–1120 (1981).PubMedCrossRefGoogle Scholar
  34. 34.
    G.I. Bell, M.J. Selby, and W.J. Rutter, The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences, Nature 295: 31–35 (1982).PubMedCrossRefGoogle Scholar
  35. 35.
    A. Ullrich, T.J. Dull, A. Gray, J.A. Philips III, and S. Peter, Variation in the sequence and modification state of the human insulin gene flanking regions, Nucleic Acids Res. 10: 2226–2240 (1982).CrossRefGoogle Scholar
  36. 36.
    P.S. Rotwein, J. Chirgwin, M. Province, W.C. Knowler, D.J. Pettitt, B. Cordell, H.M. Goodman, and H.A. Permutt, Polymorphism in the 5’-flanking region of the human insulin gene: A genetic marker for non-insulin-dependent diabetes, New Engl. J. Med. 308: 65–71 (1983).Google Scholar
  37. 37.
    G.I. Bell, J.H. Karam, and W.J. Rutter, Polymorphic DNA region adjacent to the 5’ end of the human insulin gene, Proc. Natl. Acad. Sci. USA, 78: 5759–5763 (1983).CrossRefGoogle Scholar
  38. 38.
    D. Owerbach, and J. Nerup, Restriction fragment length polymorphism of the insulin gene in diabetes mellitus, Diabetes 31: 275–277 (1982).PubMedCrossRefGoogle Scholar
  39. 39.
    G.I. Bell, S. Horita, and J.H. Karam, A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus, Diabetes 33: 176 (1984).PubMedCrossRefGoogle Scholar
  40. 40.
    J.I. Bell, J.S. Wainscoat, J.M. Old, C. Chlouverakis, H. Keen, R.C. Turnver, and D.J. Weatherall, maturity onset diabetes of the young is not linked to the insulin gene. Br. Med. J. 286: 590–592 (1982).CrossRefGoogle Scholar
  41. 41.
    T. Mandrup-Poulsen, D. Owerbach, S.A. Mortensen, K. Johansen, H. Meinertz, H. Sorensen, and J. Nerup, DNA-sequences flanking the insulin gene on chromosome 11 confer risk of atherosclerosis, Lancet 1: 250–252 (1984).Google Scholar
  42. 42.
    N.I. Jowett, L.G. Williams, G.A. Hitman, and D.J. Galton, Diabetic hypertriglyceridaemia and related 5’-flanking polymorphism of the human insulin gene, Br. Med. J. 288: 96–99 (1984).CrossRefGoogle Scholar
  43. 43.
    S.W. Serjeantson, D. Owerbach, P. Zimmet, J. Nerup, and K. Thoma, Genetics of diabetes in Nauru: Effects of foreign admixture, HLA antigens and the insulin-gene-linked polymorphism, Diabetologia 25: 13–17 (1983).PubMedCrossRefGoogle Scholar
  44. 44.
    G.F. Cahill, Jr., and H.O. McDevitt, Insulin-dependent diabetes mellitus: the initial lesion, N. Engl. J. Med. 304: 1454 (1981).PubMedCrossRefGoogle Scholar
  45. 45.
    J.F. Kaufman, C. Auffray, A.J. Korman, D.A. Shackelford, and J. Strominger, The Class II molecules of the human and murine major histocompatibility complex. Cell 36: 1 (1984).PubMedCrossRefGoogle Scholar
  46. 46.
    W.C. Knowler, D.J. Pettitt, B. Vasquez, P.S. Rotwein, T.L. Andreone, and M.A. Permutt, Polymorphism in the S’-flanking region of the human insulin gene: Relationships with non-insulin-dependent diabetes mellitus, glucose and insulin concentrations, and diabetes treatment in the Pima Indians. J. Clin. Invest. 74: 2129 (1984).PubMedCrossRefGoogle Scholar
  47. 47.
    T. Andreone, S. Fajans, P. Rotwein, W. Skolnick, and M.A. Permutt, Insulin gene analysis in a family with maturity onset diabetes of the young. Diabetes (in press).Google Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • M. Alan Permutt
    • 1
  • Teresa Andreone
    • 1
  • John Chirgwin
    • 1
  • Steve Elbein
    • 1
  • Peter Rotwein
    • 1
  • Matthew Orland
    • 1
  1. 1.Washington University School of MedicineSt. LouisUSA

Personalised recommendations